Atropine Shortage Update: What Patients Need to Know in 2026

Atropine Shortage in 2026: What's Going On?

If you rely on Atropine — whether for a heart condition, an eye problem, or emergency preparedness — you've probably noticed it's gotten harder to find. The Atropine shortage that has been building over the past few years is still affecting patients in 2026.

This guide covers everything you need to know: whether Atropine is still in shortage, why it's so hard to find, what it costs right now, and what you can do to get your prescription filled.

Is Atropine Still in Shortage in 2026?

Yes. As of early 2026, Atropine Sulfate Injection remains on the FDA and ASHP drug shortage lists. Certain formulations — particularly prefilled syringes — continue to have significant supply constraints.

Here's the current picture:

• Pfizer discontinued its Atropine Abboject LifeShield syringes in mid-2025, removing a major source of supply
• Somerset/Civica has some formulations on back order, with estimated resupply dates for 5 mL syringes pushed to December 2028 and 10 mL syringes to January 2026
• Fresenius Kabi, Hikma, and Medefil currently have Atropine injection available, but supply may vary by region
• Ophthalmic formulations (eye drops) have also experienced intermittent shortages, though generic 1% drops are generally more accessible than injectable forms

Why Is Atropine Hard to Find?

The shortage is driven by several overlapping factors:

Manufacturer Exits and Discontinuations

When a major company like Pfizer stops making a product, the remaining manufacturers can't always scale up quickly enough to fill the gap. The pharmaceutical industry has seen a wave of injectable medication discontinuations in recent years, and Atropine has been caught in that trend.

Complex Sterile Manufacturing

Injectable Atropine must be produced in sterile facilities that meet FDA standards. These facilities are expensive to build, maintain, and inspect. Quality issues or facility problems at even one manufacturer can create ripple effects across the entire supply.

Increased Demand

Demand for Atropine has grown, particularly for low-dose ophthalmic formulations used in myopia control for children. Emergency preparedness stockpiling also drives demand for the injectable form and AtroPen auto-injectors.

Limited Supplier Base

Only a handful of companies manufacture Atropine in the U.S. With such a small number of suppliers, any disruption at one company creates an outsized impact on nationwide availability.

How Much Does Atropine Cost in 2026?

The cost of Atropine varies significantly depending on the formulation:

• Atropine ophthalmic solution 1% (5 mL): $20 to $54 retail; as low as $21 with a coupon from GoodRx or SingleCare
• Atropine Sulfate injection vials: $37 to $318+ depending on concentration and quantity
• AtroPen auto-injectors: $300 to $800+ per unit — these are primarily used for nerve agent poisoning and are expensive due to their specialized delivery system
• Compounded low-dose Atropine eye drops (0.01%): $30 to $75 per bottle from specialty compounding pharmacies

For tips on reducing your costs, check out our guide on how to save money on Atropine.

Are There New Options for Patients?

There are some positive developments to be aware of:

• Medefil launched FDA-approved prefilled Atropine syringes in late 2023, adding a new supplier specifically to address the emergency syringe shortage
• Compounding pharmacies are increasingly offering low-dose Atropine eye drops for myopia control, providing an alternative when commercial products are unavailable
• Specialty distributors are working to allocate Atropine injection to the facilities that need it most

Your doctor may also be able to prescribe an alternative medication depending on your specific needs.

How to Find Atropine in Stock

Here's your action plan:

1. Use Medfinder to check real-time Atropine availability at pharmacies near you
2. Call independent pharmacies and compounding pharmacies — they often have access to different suppliers than the big chains
3. Ask your prescriber about hospital pharmacies or specialty distributors that may have stock
4. Plan ahead — don't wait until your last dose to start looking for a refill
5. Check back frequently — pharmacy stock changes daily during a shortage

For more detailed strategies, read our full guide on how to find Atropine in stock near you.

Final Thoughts

The Atropine shortage in 2026 is real, but it's not hopeless. Atropine is still being manufactured by multiple companies, and new supply sources have come online in recent years. The key is knowing where to look, being proactive about refills, and working closely with your healthcare team.

Use Medfinder to stay on top of availability, and explore our other resources including Atropine side effects and finding a doctor who prescribes Atropine.